Chemomab Therapeutics Ltd

CMMB NASDAQ Santé & Biotech Marchés Émergeants US16385C1045
1.94 $
3.21 %

Chemomab Therapeutics Ltd se spécialise dans la recherche et le développement de thérapies novatrices pour le traitement des maladies fibrotiques et inflammatoires.

Performance & Momentum

6 Months 26.72 %
1 Year 65.71 %
3 Years 69.62 %
5 Years 97.29 %

Similar stocks to Chemomab Therapeutics Ltd

Anantys Community

Be the first to share your analysis on Chemomab Therapeutics Ltd.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases